On one hand, CCR2 expression promotes tumor associated macrophages (TAMs) and fibroblast recruitment at the primary tumors, where they enhance invasion, angiogenesis and metastasis of breast, glioma, lung and prostate cancer, melanoma, and multiple myeloma [19]. The gene discussed is CCR2; the disease is prostate carcinoma.